SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-003917
Filing Date
2023-02-08
Accepted
2023-02-08 09:34:20
Documents
13
Period of Report
2023-02-07
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 64674
  Complete submission text file 0001493152-23-003917.txt   299492

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aeha-20230207.xsd EX-101.SCH 4404
3 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT aeha-20230207_def.xml EX-101.DEF 27307
4 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aeha-20230207_lab.xml EX-101.LAB 37849
5 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aeha-20230207_pre.xml EX-101.PRE 25927
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 7169
Mailing Address 515 MADISON AVE SUITE 8078 NEW YORK NY 10022
Business Address 515 MADISON AVE SUITE 8078 NEW YORK NY 10022 (646) 908-2658
Aesther Healthcare Acquisition Corp. (Filer) CIK: 0001869974 (see all company filings)

IRS No.: 871309280 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40793 | Film No.: 23597351
SIC: 2834 Pharmaceutical Preparations